AAAAAA
Results: 1-25/51
Authors:
SCULIER JP
Citation: Jp. Sculier, SHOULD MAINTENANCE CHEMOTHERAPY BE USED TO TREAT SMALL-CELL LUNG-CANCER - PRO, European journal of cancer, 34(8), 1998, pp. 1148-1151
Authors:
SCULIER JP
PAESMANS M
BUREAU G
RECLOUX P
BAUMOHL J
VANCUTSEM O
BERCHIER MC
THIRIAUX J
LAFITTE JJ
MOMMEN P
VANHOUTTE P
NINANE V
KLASTERSKY J
Citation: Jp. Sculier et al., A PHASE-III RANDOMIZED STUDY COMPARING, IN NON METASTATIC UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) RESPONDING TO CHEMOTHERAPY (CT), FURTHER CT TO LOCO-REGIONAL IRRADIATION (RT), Annals of oncology, 9, 1998, pp. 399-399
Authors:
BAUMOHL J
SCULIER JP
PAESMANS M
BUREAU G
RECLOUX P
VANCUTSEM O
BERCHIER MC
THIRIAUX J
LAFITTE JJ
MOMMEN P
VANHOUTTE P
NINANE V
KLASTERSKY J
Citation: J. Baumohl et al., IS CHEMOSENSITIVITY A PREDICTIVE FACTOR FOR RADIOSENSITIVITY IN NONSMALL CELL LUNG-CANCER - LESSON FROM EUROPEAN LUNG-CANCER WORKING PARTY PHASE-III RANDOMIZED TRAIL, Annals of oncology, 9, 1998, pp. 402-402
Authors:
PAESMANS M
BERGHMANS T
LALAMI Y
LEMAITRE F
LOUVIAUX I
LUCE S
PEGRIMOCOVA R
VERMYLEN P
SCULIER JP
Citation: M. Paesmans et al., A LITERATURE-BASED QUALITATIVE AND QUANTITATIVE OVERVIEW OF CHEMOTHERAPY FOR MALIGNANT MESOTHELIOMA, Annals of oncology, 9, 1998, pp. 459-459
Authors:
LUCE S
PAESMANS M
BERGHMANS T
CASTAIGNE C
SOTIRIOU C
VERMYLEN P
SCULIER JP
Citation: S. Luce et al., CRITICAL-REVIEW OF THE RANDOMIZED TRIALS ASSESSING THE ROLE OF ADJUVANT THORACIC IRRADIATION IN LIMITED DISEASE SMALL-CELL LUNG-CANCER, Revue des maladies respiratoires, 15(5), 1998, pp. 633-641
Authors:
SCULIER JP
QUOIX E
Citation: Jp. Sculier et E. Quoix, THERAPEUTIC STRATEGIES ACCORDING TO THE CLINICAL TNM, Revue des maladies respiratoires, 15(3BIS), 1998, pp. 319-322
Authors:
SCULIER JP
PAESMANS M
THIRIAUX J
LECOMTE J
BUREAU G
GINER V
EFREMIDIS A
LAFITTE JJ
BERCHIER MC
ALEXOPOULOS CG
ZACHARIAS C
MOMMEN P
NINANE V
KLASTERSKY J
Citation: Jp. Sculier et al., PHASE-III RANDOMIZED TRIAL COMPARING CISPLATIN AND CARBOPLATIN WITH OR WITHOUT IFOSFAMIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1388-1396
Authors:
SCULIER JP
BERGHMANS T
CASTAIGNE C
LUCE S
SOTIRIOU C
VERMYLEN P
PAESMANS M
Citation: Jp. Sculier et al., REPLY TO THE LETTER OF TRILLETLENOIR,V. ON SYSTEMATIC REVIEW ABOUT THE LITERATURE ON MAINTENANCE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Lung cancer, 21(3), 1998, pp. 225-226
Authors:
SCULIER JP
BERGHMANS T
CASTAIGNE C
LUCE S
SOTIRIOU C
VERMYLEN P
PAESMANS M
Citation: Jp. Sculier et al., MAINTENANCE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - A CRITICAL-REVIEW OF THE LITERATURE, Lung cancer, 19(2), 1998, pp. 141-151
Authors:
BERGHMANS T
LUCE S
PAESMANS M
CASTAIGNE C
SOTIRIOU C
VERMYLEN P
SCULIER JP
Citation: T. Berghmans et al., RANDOMIZED TRIALS EVALUATING RADIOTHERAPY ADJUVANT TO CHEMOTHERAPY FOR SMALL-CELL LUNG-CARCINOMA (SCLC) - QUALITATIVE EVALUATION BEFORE METAANALYSIS, European journal of cancer, 33, 1997, pp. 1034-1034
Authors:
PAESMANS M
SCULIER JP
LIBERT P
BUREAU G
DABOUIS G
THIRIAUX J
MICHEL J
VANCUTSEM O
SERGYSELS R
MOMMEN P
KLASTERSKY J
Citation: M. Paesmans et al., RESPONSE TO CHEMOTHERAPY HAS PREDICTIVE VALUE FOR FURTHER SURVIVAL OFPATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - 10 YEARS EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, European journal of cancer, 33(14), 1997, pp. 2326-2332
Authors:
BERGHMANS T
CROKAERT F
MARKIEWICZ E
SCULIER JP
Citation: T. Berghmans et al., EPIDEMIOLOGY OF INFECTIONS IN THE ADULT MEDICAL INTENSIVE-CARE UNIT OF A CANCER HOSPITAL, Supportive care in cancer, 5(3), 1997, pp. 234-240
Authors:
SCULIER JP
PAESMANS M
LIBERT P
BUREAU G
DABOUIS G
THIRIAUX J
MICHEL J
VANCUTSEM O
SCHMERBER J
GINER V
BERCHIER MC
MOMMEN P
SERGYSELS R
KLASTERSKY J
Citation: Jp. Sculier et al., THE PROGNOSTIC FACTORS FOR ADVANCED NONSM ALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, Revue des maladies respiratoires, 14(6), 1997, pp. 445-449
Authors:
SCULIER JP
MARKIEWICZ E
FOUBERT J
Citation: Jp. Sculier et al., CENTRAL VENOUS CATHETERS WITH TOTALLY IMP LANTED INJECTION PORT - USEAND FOLLOW-UP, Revue des maladies respiratoires, 14(3), 1997, pp. 235-236
Authors:
SCULIER JP
Citation: Jp. Sculier, SIGNIFICANCE OF TUMOR-MARKERS IN MONITORI NG OF PRIMARY LUNG-CANCER AND ASSESSMENT OF THERAPEUTIC EFFICACY, Revue des maladies respiratoires, 14, 1997, pp. 23-26
Authors:
SCULIER JP
Citation: Jp. Sculier, THE NEW-WAVE OF THERAPEUTIC CHEMICAL-AGEN TS - STATE-OF-THE-ART ON LUNG-CARCINOMA, Revue des maladies respiratoires, 14(2), 1997, pp. 154-156
Authors:
VERMYLEN P
ROUFOSSE C
NINANE V
SCULIER JP
Citation: P. Vermylen et al., BIOLOGY OF PULMONARY PRENEOPLASTIC LESIONS, Cancer treatment reviews, 23(4), 1997, pp. 241-262
Authors:
PERRY MC
DESLAURIERS J
ALBAIN KS
CHOI NC
DEPIERRE A
JOHNSTON MR
LACQUET LK
PAYNE DG
PUTNAM JB
SCULIER JP
SHEPHERD FA
Citation: Mc. Perry et al., INDUCTION TREATMENT FOR RESECTABLE NON-SMALL-CELL LUNG-CANCER, Lung cancer, 17, 1997, pp. 15-18
Authors:
ADEDOYIN A
BERNARDO JF
SWENSON CE
BOLSACK LE
HORWITH G
DEWIT S
KELLY E
KLASTERKSY J
SCULIER JP
DEVALERIOLA D
ANAISSIE E
LOPEZBERESTEIN G
LLANOSCUENTAS A
BOYLE A
BRANCH RA
Citation: A. Adedoyin et al., PHARMACOKINETIC PROFILE OF ABELCET (AMPHOTERICIN-B LIPID COMPLEX INJECTION) - COMBINED EXPERIENCE FROM PHASE-I AND PHASE-II STUDIES, Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2201-2208
Authors:
SCULIER JP
PAESMANS M
BUREAU G
GINER V
LECOMTE J
MICHEL J
BERCHIER MC
VANCUTSEM O
KUSTNER U
KROLL F
SERGYSELS R
MOMMEN P
KLASTERSKY J
Citation: Jp. Sculier et al., RANDOMIZED TRIAL COMPARING INDUCTION CHEMOTHERAPY VERSUS INDUCTION CHEMOTHERAPY FOLLOWED BY MAINTENANCE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2337-2344
Authors:
BORGES M
SCULIER JP
PAESMANS M
RICHEZ M
BUREAU G
DABOUIS G
LECOMTE J
MICHEL J
VANCUTSEM O
SCHMERBER J
GINER V
BERCHIER MC
SERGYSELS R
MOMMEN P
KLASTERSKY J
Citation: M. Borges et al., PROGNOSTIC FACTORS FOR RESPONSE TO CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVES IN PATIENTS WITH UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC), Lung cancer, 16(1), 1996, pp. 21-33
Authors:
SCULIER JP
MARKIEWICZ E
Citation: Jp. Sculier et E. Markiewicz, CARDIOPULMONARY-RESUSCITATION IN CANCER-P ATIENTS - EXPERIENCE OF AN INTENSIVE-CARE UNIT IN A CANCER CENTER, Bulletin du cancer, 83(8), 1996, pp. 677-681
Authors:
SCULIER JP
BUREAU G
THIRIAUX J
LECOMTE J
RECLOUX P
BERCHIER MC
KROLL F
BROHEE D
MOMMEN P
PAESMANS M
SERGYSELS R
KLASTERSKY J
Citation: Jp. Sculier et al., A PHASE-II STUDY TESTING A COMBINATION CHEMOTHERAPY WITH EPIRUBICIN AND VINDESINE AS 2ND LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, International journal of oncology, 7(5), 1995, pp. 1175-1178
Authors:
SCULIER JP
THIRIAUX J
BUREAU G
LAFITTE JJ
RECLOUX P
BROHEE D
BERCHIER MC
SERGYSELS R
MOMMEN P
PAESMANS M
KLASTERSKY J
LECOMTE J
VANSCHAARDENBURG C
RICHARD V
DIANA D
FORTIN F
TAGNON A
KUSTNER U
Citation: Jp. Sculier et al., A PHASE-II STUDY TESTING WEEKLY PLATINUM DERIVATIVE COMBINATION CHEMOTHERAPY AS 2ND-LINE TREATMENT IN PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER, International journal of oncology, 6(2), 1995, pp. 425-429
Authors:
SCULIER JP
BUREAU G
GINER V
THIRIAUX J
MOMMEN P
PAESMANS M
KLASTERSKY J
Citation: Jp. Sculier et al., MAINTENANCE CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER AFTER INDUCTION CHEMOTHERAPY WITH IFOSFAMIDE, ETOPOSIDE AND ANTHRACYCLIN -RANDOMIZED TRIAL CONDUCTED BY THE EUROPEAN LUNG-CANCER WORKING PARTY, European journal of cancer, 31A, 1995, pp. 81-81